Before the baby is 2 years old, he needs to inject dozens of doses of vaccine. The child is in pain and parents are in trouble. Changing this situation has always been the goal of vaccine researchers. Professor Protkin, an internationally renowned vaccine expert, said at the International Symposium on the Development and Application of Combined Vaccines on the 15th that "inoculation with a combined vaccine has become an inevitable trend."
The International Symposium on Joint Vaccine Development and Application, sponsored by the Chinese Preventive Medical Association and co-sponsored by Sanofi Pasteur Biopharmaceutical Co., Ltd., was held in Beijing from the 14th to the 15th. Vaccine experts at home and abroad discussed joint vaccines at the conference. Develop and apply development trends.
Dr. Protekin is an emeritus professor at the University of Pennsylvania. He wrote "Vaccineology" as a standard textbook and the rubella vaccine developed is also used as a standard in the world.
“The best way to keep infants and young children away from the threat of disease is to get vaccinated.†He said that vaccinating the combined vaccine can not only reduce the number of injections, increase the vaccination rate, and is easy to operate. It has been used internationally to prevent childhood diseases, such as It can prevent five pairs of children with diphtheria, whooping cough, tetanus, polio, and Haemophilus influenzae type b disease.
According to reports, the combined vaccine is a combination of several vaccine antigens. It includes two major categories: multi-linked vaccines and multivalent vaccines. Multi-component vaccines are composed of a variety of pathogenic antigens and are used to prevent a variety of diseases, such as the "white pit" vaccine. Multivalent vaccines are vaccines that contain different subtypes or serotypes of the same bacteria or virus, such as the 7-valent Streptococcus pneumoniae vaccine.
The concept of combined vaccines began in the 1930s. Today, more than 100 countries around the world use a combination vaccine. Yang Yonghong, a professor at the Beijing Children's Hospital, said that the combined vaccine has reduced the total number of inoculations, the mother has less effort, and the baby suffers fewer crimes. At the same time, because of the reduced number of inoculations, it is possible to reduce the occurrence of adverse reactions.
According to Professor Shen Xuzhuang of the Beijing Children's Hospital, China is conducting a safety test on the prevention of common infectious diseases in infants and young children, and it is expected to be listed in China next year.
In addition, the participating vaccine experts also elaborated on the five characteristics of future children's vaccines: a single immunization after the birth of the baby should be effective to improve the coverage of the vaccine; the application of the latest technology for the combination of vaccines, reducing the number of vaccination and increasing preventable diseases Quantity; should have thermal stability, improve the thermal stability of the vaccine can expand the immune effect, while reducing vaccine waste and refrigeration costs. In addition, future vaccines should also be effective against more diseases and at a reasonable price.
The International Symposium on Joint Vaccine Development and Application, sponsored by the Chinese Preventive Medical Association and co-sponsored by Sanofi Pasteur Biopharmaceutical Co., Ltd., was held in Beijing from the 14th to the 15th. Vaccine experts at home and abroad discussed joint vaccines at the conference. Develop and apply development trends.
Dr. Protekin is an emeritus professor at the University of Pennsylvania. He wrote "Vaccineology" as a standard textbook and the rubella vaccine developed is also used as a standard in the world.
“The best way to keep infants and young children away from the threat of disease is to get vaccinated.†He said that vaccinating the combined vaccine can not only reduce the number of injections, increase the vaccination rate, and is easy to operate. It has been used internationally to prevent childhood diseases, such as It can prevent five pairs of children with diphtheria, whooping cough, tetanus, polio, and Haemophilus influenzae type b disease.
According to reports, the combined vaccine is a combination of several vaccine antigens. It includes two major categories: multi-linked vaccines and multivalent vaccines. Multi-component vaccines are composed of a variety of pathogenic antigens and are used to prevent a variety of diseases, such as the "white pit" vaccine. Multivalent vaccines are vaccines that contain different subtypes or serotypes of the same bacteria or virus, such as the 7-valent Streptococcus pneumoniae vaccine.
The concept of combined vaccines began in the 1930s. Today, more than 100 countries around the world use a combination vaccine. Yang Yonghong, a professor at the Beijing Children's Hospital, said that the combined vaccine has reduced the total number of inoculations, the mother has less effort, and the baby suffers fewer crimes. At the same time, because of the reduced number of inoculations, it is possible to reduce the occurrence of adverse reactions.
According to Professor Shen Xuzhuang of the Beijing Children's Hospital, China is conducting a safety test on the prevention of common infectious diseases in infants and young children, and it is expected to be listed in China next year.
In addition, the participating vaccine experts also elaborated on the five characteristics of future children's vaccines: a single immunization after the birth of the baby should be effective to improve the coverage of the vaccine; the application of the latest technology for the combination of vaccines, reducing the number of vaccination and increasing preventable diseases Quantity; should have thermal stability, improve the thermal stability of the vaccine can expand the immune effect, while reducing vaccine waste and refrigeration costs. In addition, future vaccines should also be effective against more diseases and at a reasonable price.
Finished products of varicella vaccine. It has three qualities,good safety of gelatin-free, long validity period by good stability, better protection with high titer and immune efficacy. These improvements enhanced the vaccine safety and quality, and established BCHT the leading position in varicella vaccine. We have two different packages, penicillin bottle and pre-filled syringe. And it has been exported to other countries, such as India, Philippines.
Varicella Vaccine Finished Products
Finished Products Of Rabies Vaccine,Rabies Vaccine For Human Use,Live Biotechnology Chicken Pox,Live Lyophilized Vaccination
Changchun BCHT Biotechnology Co.,Ltd , https://www.ccbcht.net